FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.

by Marci A. Landsmann

A blood test for tumor mutations shows promise as an option for lung cancer patients, and the U.S. Food and Drug Administration expresses concern about robotically-assisted cancer surgery.

by Kate Yandell

Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.

by Kate Yandell

Guidelines recommend that all breast cancer patients be offered genetic testing, and a report indicates that disparities in cancer incidence and mortality between black and white Americans are getting smaller.

by Kate Yandell

A study finds that a new shingles vaccine is safe and likely effective in adult cancer patients, and a review article shows that some cancer patients with HIV can benefit from immunotherapy.

by Kate Yandell

Unsupported claims of a “complete cure” for cancer spread across the internet and airwaves, and a new policy aims to increase inclusion of older patients in research.

by Kate Yandell

A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.

by Kate Yandell

A study sheds light on predicting immunotherapy response, and a company starts testing a digital chemotherapy pill.

by Kate Yandell

Government guidance asks hospitals to post prices online, and a study shows that cancer patients are less likely to enroll in clinical trials if they have coexisting health conditions.

by Kate Yandell

A financial transparency law goes into effect, researchers investigate a link between hot flashes and breast cancer, and the hunt for a better synthetic cell culture medium.

by Brad Jones